Researchers at UT Southwestern Medical Center and in Australia have shown that a drug currently in testing shows potential to cure malaria in a single dose and offers promise as a preventive treatment as well.
The new drug – DSM265 kills drug-resistant malaria parasites in the blood and liver by targeting their ability to replicate. Malaria is a highly infectious, mosquito-transmitted disease that kills nearly 600,000 people worldwide each year, mostly children under 5 years old living in sub-Saharan Africa. Nearly 200 million cases of malaria are reported annually, and about 3 billion people are at risk of malaria in 97 countries.
“DSM265 could be among the first single-dose cures for malaria, and would be used in partnership with another drug,” said lead author Dr. Margaret Phillips, Professor of Pharmacology at UT Southwestern. “The drug also could potentially be developed as a once-weekly preventive.”
The research team included UT Southwestern, the Monash Institute of Pharmaceutical Sciences in Australia, the University of Washington, and the not-for-profit Medicines for Malaria Venture (MMV). The study was published inScience Translational Medicine.
Researchers determined that the compound DSM265 kills the malaria parasite Plasmodium in both liver and blood stages of infection. Further, the compound was shown to be well tolerated and effective in preclinical models.
Currently, the frontline anti-malarial treatments are artemisinin-based combination therapies, or ACTs, which are credited with helping to reduce the malaria burden. However, malaria strains resistant to ACTs have recently been reported in Thailand, Cambodia, Vietnam, Myanmar, and Laos.
“The problem is we’re starting to see more drug resistance, and this is what’s taken out every anti-malarial drug we’ve had,” said Dr. Phillips, who holds the Beatrice and Miguel Elias Distinguished Chair in Biomedical Science, and the Carolyn R. Bacon Professorship in Medical Science and Education. “The parasite is very good at adapting and becoming resistant to drugs ? this is inevitable. What we can do is deliver new medicines with new modes of action and safeguard the longevity of the anti-malarial through use in combination as long as possible.”
In order to combat drug resistance, DSM265 likely would be partnered with another new drug and used as a one-dose combination therapy. Another option is to develop DSM265 as a once-weekly preventive for individuals traveling to malaria-endemic regions or for people living in areas where malaria infections are primarily seasonal and human immunity is low. Either scenario is still several years away, pending the outcome of current and future trials, said Dr. Phillips.
DSM265 targets the ability of the parasite to synthesize the nucleotide precursors required for synthesis of DNA and RNA, said Dr. Phillips.
The study concluded that DSM265 appeared to be safely tolerated in non-human tests and established optimal dosing levels and length of drug effectiveness in preclinical models to estimate dosing for humans, paving the way for clinical trials. The first clinical trial was a safety study in Australia, followed by an ongoing efficacy study in Peru to evaluate the ability to treat patients with malaria. Additional human studies are planned, including one to test the drug as a preventive medicine. UT Southwestern is assisting in an advisory capacity in these studies and is providing support with biomarker assays.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- Fear of malaria, dengue looms as waterlogging persists in Gurgaonon July 22, 2019 at 6:55 pm
Gurgaon: Monsoon showers in the city have resulted in stagnant water on internal roads in several colonies, creating breeding grounds for mosquitoes and triggering fears of malaria and dengue. ... […]
- Drug-resistant malaria parasites 'spreading aggressively' across south-east Asiaon July 22, 2019 at 6:34 pm
The deadly Plasmodium falciparum malaria parasite, which is transmitted by mosquitoes, is becoming more resistant to drugs. Photograph: Alamy Stock Photo Drug-resistant forms of malaria-causing ... […]
- Experts sound alarm over drug-resistant malaria strainon July 22, 2019 at 5:04 pm
Multidrug-resistant forms of malaria-causing parasites are spreading across southeast Asia leading to "alarmingly high" treatment failure rates of widely used frontline medication, researchers have ... […]
- Resistant malaria spreading in South-East Asiaon July 22, 2019 at 4:54 pm
Malaria parasites resistant to key drugs have spread rapidly in South-East Asia, researchers from the UK and Thailand say. The parasites have moved from Cambodia to Laos, Thailand and Vietnam, where ... […]
- Multidrug-resistant malaria spreading in Southeast Asia - studyon July 22, 2019 at 3:47 pm
LONDON (Reuters) - Strains of malaria resistant to two key anti-malarial medicines are becoming more dominant in Vietnam, Laos and northern Thailand after spreading rapidly from Cambodia, scientists ... […]
- Multi-drug resistant parasites threaten global efforts to control malaria, experts warnon July 22, 2019 at 3:40 pm
Only half of patients with malaria in south east Asian countries are being cured because multi-drug resistant forms of the parasite are now so widespread, researchers have found. According to two ... […]
- Study: Malaria Drugs Are Failing At An 'Alarming' Rate In Southeast Asiaon July 22, 2019 at 3:31 pm
Malaria drugs are failing at an "alarming" rate in Southeast Asia as drug-resistant strains of the malaria parasite emerge. Global health officials get nervous when new strains of drug-resistant ... […]
- Avian malaria behind drastic decline of London's iconic sparrow?on July 17, 2019 at 6:05 pm
London's house sparrows (Passer domesticus) have plummeted by 71% since 1995, with new research suggesting avian malaria could be to blame. Once ubiquitous across the capital city, the sudden, and ... […]
- Support for Global Fund imperative as U.S. tries to save lives from TB, malaria, AIDSon July 17, 2019 at 3:10 pm
Before I was pastor of The Cornerstone Church, I spent a year with at-risk kids in Thailand. There, I witnessed the systemic impacts of poverty. My faith calls me to uplift the vulnerable, in Boise ... […]
- Avian malaria may explain decline of London's house sparrowon July 17, 2019 at 7:44 am
July 17 (UPI) --Since 1995, London's iconic house sparrow population has declined 71 percent. New research suggests avian malaria is the primary driver of the population decline. New tests showed ... […]
via Bing News